Literature DB >> 15752909

Inverse treatment planning based on MRI for HDR prostate brachytherapy.

Deborah Citrin1, Holly Ning, Peter Guion, Guang Li, Robert C Susil, Robert W Miller, Etienne Lessard, Jean Pouliot, Xie Huchen, Jacek Capala, C Norman Coleman, Kevin Camphausen, Cynthia Ménard.   

Abstract

PURPOSE: To develop and optimize a technique for inverse treatment planning based solely on magnetic resonance imaging (MRI) during high-dose-rate brachytherapy for prostate cancer. METHODS AND MATERIALS: Phantom studies were performed to verify the spatial integrity of treatment planning based on MRI. Data were evaluated from 10 patients with clinically localized prostate cancer who had undergone two high-dose-rate prostate brachytherapy boosts under MRI guidance before and after pelvic radiotherapy. Treatment planning MRI scans were systematically evaluated to derive a class solution for inverse planning constraints that would reproducibly result in acceptable target and normal tissue dosimetry.
RESULTS: We verified the spatial integrity of MRI for treatment planning. MRI anatomic evaluation revealed no significant displacement of the prostate in the left lateral decubitus position, a mean distance of 14.47 mm from the prostatic apex to the penile bulb, and clear demarcation of the neurovascular bundles on postcontrast imaging. Derivation of a class solution for inverse planning constraints resulted in a mean target volume receiving 100% of the prescribed dose of 95.69%, while maintaining a rectal volume receiving 75% of the prescribed dose of <5% (mean 1.36%) and urethral volume receiving 125% of the prescribed dose of <2% (mean 0.54%).
CONCLUSION: Systematic evaluation of image spatial integrity, delineation uncertainty, and inverse planning constraints in our procedure reduced uncertainty in planning and treatment.

Entities:  

Mesh:

Year:  2005        PMID: 15752909     DOI: 10.1016/j.ijrobp.2004.11.024

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

1.  Dosimetric evaluation of high-dose-rate interstitial brachytherapy boost treatments for localized prostate cancer.

Authors:  Georgina Fröhlich; Péter Agoston; József Lövey; András Somogyi; János Fodor; Csaba Polgár; Tibor Major
Journal:  Strahlenther Onkol       Date:  2010-06-24       Impact factor: 3.621

2.  Open MR-guided high-dose-rate (HDR) prostate brachytherapy: feasibility and initial experiences open MR-guided high-dose-rate (HDR) prostate brachytherapy.

Authors:  Ferenc Lakosi; Gergely Antal; Csaba Vandulek; Arpad Kovacs; Gabor L Toller; Istvan Rakasz; Gabor Bajzik; Janaki Hadjiev; Peter Bogner; Imre Repa
Journal:  Pathol Oncol Res       Date:  2011-01-11       Impact factor: 3.201

3.  Fast dose optimization for rotating shield brachytherapy.

Authors:  Myung Cho; Xiaodong Wu; Hossein Dadkhah; Jirong Yi; Ryan T Flynn; Yusung Kim; Weiyu Xu
Journal:  Med Phys       Date:  2017-09-11       Impact factor: 4.071

Review 4.  Magnetic resonance image guided brachytherapy.

Authors:  Kari Tanderup; Akila N Viswanathan; Christian Kirisits; Steven J Frank
Journal:  Semin Radiat Oncol       Date:  2014-07       Impact factor: 5.934

5.  Class solution in inverse planned HDR prostate brachytherapy for dose escalation of DIL defined by combined MRI/MRSI.

Authors:  Yongbok Kim; I-Chow J Hsu; Etienne Lessard; John Kurhanewicz; Susan Moyher Noworolski; Jean Pouliot
Journal:  Radiother Oncol       Date:  2008-02-20       Impact factor: 6.280

Review 6.  Imaging in radiation oncology: a perspective.

Authors:  Laura A Dawson; Cynthia Ménard
Journal:  Oncologist       Date:  2010

7.  Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided high dose rate brachytherapy boost.

Authors:  Anurag K Singh; Peter Guion; Robert C Susil; Deborah E Citrin; Holly Ning; Robert W Miller; Karen Ullman; Sharon Smith; Nancy Sears Crouse; Denise J Godette; Bronwyn R Stall; C Norman Coleman; Kevin Camphausen; Cynthia Ménard
Journal:  Radiat Oncol       Date:  2006-08-16       Impact factor: 3.481

8.  Does help structures play a role in reducing the variation of dwell time in IPSA planning for gynaecological brachytherapy application?

Authors:  Swamidas Jamema; Umesh Mahantshetty; Dd Deshpande; Smriti Sharma; Sk Shrivastava
Journal:  J Contemp Brachytherapy       Date:  2011-09-30

9.  Physics-aspects of dose accuracy in high dose rate (HDR) brachytherapy: source dosimetry, treatment planning, equipment performance and in vivo verification techniques.

Authors:  Antony Palmer; David Bradley; Andrew Nisbet
Journal:  J Contemp Brachytherapy       Date:  2012-06-30

10.  Urethrogram-Directed Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer in Patients with Contraindications to Magnetic Resonance Imaging.

Authors:  Ima Paydar; Brian S Kim; Robyn A Cyr; Harriss Rashid; Amna Anjum; Thomas M Yung; Siyuan Lei; Brian T Collins; Simeng Suy; Anatoly Dritschilo; John H Lynch; Sean P Collins
Journal:  Front Oncol       Date:  2015-09-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.